Citius Oncology Cash Flow Statement 2021-2024 | CTOR

Fifteen years of historical annual cash flow statements for Citius Oncology (CTOR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202320222021
$-21.15$2.42$-12.70$0.38$-0.01
$0$0$0$0$0
$8.07$-3.43$2.54$-0.49$0.01
$8.07$-3.43$2.54$-0.49$0.01
$0$0$0$0$0
$-2.13$0$0$0$0
$2.42$0$1.20$0$0
$13.17$0.06$9.76$0.04$0
$13.20$0.41$10.16$0.06$0
$0.13$-0.60$0$-0.05$0
$0$0$0$0$0
$-5.00$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$-1.32$0$-67.32$0
$0$-1.32$0$-67.32$0
$0$0$0$0$0
$-5.00$-1.32$0$-67.32$0
$3.80$0$0$0$0
$0$1.66$0$-0.13$0
$3.80$1.66$0$-0.13$0
$0$0$0$69.36$0
$0$0$0$69.36$0
$0$0$0$0$0
$1.07$0$0$-1.57$0
$4.87$1.66$0$67.66$0
$0.00$-0.26$0$0.29$0
$7.50$0$1.97$0$0
$0$0$0$0$0